Brief: Cesca Therapeutics - Thermogenesis Receives Health Canada Approval Of Its Next-Generation Axp Ii System For Cord Blood Processing
June 18 (Reuters) - Cesca Therapeutics Inc KOOL.O :
* THERMOGENESIS RECEIVES HEALTH CANADA APPROVAL OF ITS
NEXT-GENERATION AXP II SYSTEM FOR CORD BLOOD PROCESSING
Source text for Eikon: ID:nPn3RLKRa
Further company coverage: KOOL.O
((Briefs@thomsonreuters.com;))
Recent news on Thermogenesis Holdings
See all newsThermogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc reports results for the quarter ended in December - Earnings Summary
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Thermogenesis Holdings Inc expected to post a loss of 1 cent a share - Earnings Preview
Brief: Thermogenesis Holdings Says On Jan 8 Co Received Nasdaq Letter Notifying It No Longer Complies With Minimum Bid Price Requirement For Listing On Nasdaq